Results 91 to 100 of about 309,396 (215)

Mucinous Neoplasms

, 2015
Although interest in pancreatic pathology is very high in the radiological and gastroenterological communities, it is still the case that less is known about pathology of the pancreas than about liver pathology, for example.
D'ONOFRIO, Mirko, Capelli, Paola, MORANA, Giovanni, DE ROBERTIS LOMBARDI, Riccardo, Barbi, Emilio, TINAZZI MARTINI, Paolo, LUCHINI, Claudio, Crosara, Stefano   +7 more
core  

The Utilization of Imaging Features in the Management of Intraductal Papillary Mucinous Neoplasms

Gastroenterology Research and Practice, 2014
Intraductal papillary mucinous neoplasms (IPMNs) represent a group of cystic pancreatic neoplasms with large range of clinical behaviours, ranging from low-grade dysplasia or borderline lesions to invasive carcinomas.
Stefano Palmucci, Claudia Trombatore, Pietro Valerio Foti, Letizia Antonella Mauro, Pietro Milone, Roberto Milazzotto, Rosalia Latino, Giacomo Bonanno, Giuseppe Petrillo, Antonio Di Cataldo   +9 more
doaj   +1 more source

Endoscopic Ultrasound for Early Diagnosis of Pancreatic Cancer

Diagnostics, 2019
Detection of small pancreatic cancers, which have a better prognosis than large cancers, is needed to reduce high mortality rates. Endoscopic ultrasound (EUS) is the most sensitive imaging modality for detecting pancreatic lesions. The high resolution of
Takeichi Yoshida, Yasunobu Yamashita, Masayuki Kitano   +2 more
doaj   +1 more source

Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells

Biomedicines, 2017
Pancreatic Ductal Adenocarcinoma (PDAC) is the fourth most common cause of cancer-related death and is the most lethal of common malignancies with a five-year survival rate of <10%.
Elvira Pelosi, Germana Castelli, Ugo Testa   +2 more
doaj   +1 more source

Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia? [PDF]

, 2013
Most screening programs for familial pancreatic cancer are currently based on endoscopic ultrasonography and/or magnetic resonance imaging (MRI). Cystic lesions, especially those suspicious for small intraductal pancreatic mucinous neoplasms (IPMNs) of ...
Esposito, I, Heverhagen, J T, Matthaei, E, Langer, P, Dietzel, K, Gress, T M, Bargello, M, Slater, E P, Bartsch, D K, Kloeppel, G   +9 more
core   +2 more sources

Invasive squamous cell carcinoma arising from an intraductal oncocytic papillary neoplasm demonstrating shared ATP1B1::PRKACA gene fusion

Human Pathology Reports
Intraductal oncocytic papillary neoplasms (IOPN) are rare cystic pancreatic neoplasms marked by oncocytic cells and intricate papillary structures.
Wai Szeto, Safa Alshaikh, Javier A. Arias-Stella, III, Yuman Fong, Rifat Mannan   +4 more
doaj   +1 more source

Intraductal papillary mucinous neoplasm of the pancreas with a bifid pancreatic duct

Journal of Hepato-Biliary-Pancreatic Surgery, 2009
A bifid pancreatic duct presenting a major bifurcation in the main pancreatic duct is one of the anatomical variations of the pancreatic ducts. We encountered a 71-year-old female with a 5-cm-diameter branch duct intraductal papillary mucinous neoplasm of the pancreas in whom preoperative endoscopic retrograde pancreatography demonstrated an anomalous ...
Yoshitsugu, Tajima, Tomohiko, Adachi, Tamotsu, Kuroki, Noritsugu, Tsuneoka, Takehiro, Mishima, Taiichiro, Kosaka, Takashi, Kanematsu   +6 more
openaire   +2 more sources

Intraductal Papillary Mucinous Neoplasm (IPMN)

, 2022
Intraductal papillary mucinous neoplasms (IPMNs) are a group of exocrine mucin-producing tumors, diagnosed at a mean age of 60 years, with male prevalence. Improvements in imaging techniques have led to an increasing incidental detection of IPMNs.
D'Onofrio, Mirko, Bardhi, Eda, Capelli, Paola, Morana, Giovanni, Martini, Paolo Tinazzi, Luchini, Claudio, De Robertis, Riccardo, Cardobi, Nicolò, Beleù, Alessandro   +8 more
core   +1 more source

An appraisal of pancreatic cyst fluid molecular markers

Gastrointestinal Intervention, 2017
Pancreatic malignancy is the third leading cause of cancer related death in the United States with limited viable screening options. By the end of this decade, cancers are poised to become the leading cause of death with pancreatic cancer projected to be
Rohan M. Modi, Ravi B. Pavurala, Somashekar G. Krishna   +2 more
doaj   +1 more source

Cystic fluid chromogranin A levels in different pancreatic cystic lesions

The Turkish Journal of Gastroenterology, 2015
Background/Aims: Pancreatic cystic lesions have a broad spectrum of differential diagnosis. There is an ongoing demand to identify specific and sensitive cystic fluid markers for the differential diagnosis of pancreatic cysts.
Nevin Oruç, Ahmet Aydın, Burcu Barutcuoğlu, Çağdaş Aktan, Deniz Nart, Ali Veral   +5 more
doaj   +1 more source